5 results
8-K
EX-99.1
ARAV
Aravive Inc
22 Sep 14
Regulation FD Disclosure
12:00am
study
Figure 2. Phase 1b/2a Schema
Phase 1b (Single Ascending Dose) Phase 2a (Repeat Dose)
VRS 317 Dose
(mg/kg)
Table 1. Phase 2a Demographic Data (Mean
8-K
EX-99.1
ARAV
Aravive Inc
23 Jun 14
Regulation FD Disclosure
12:00am
tests. All patients had short stature (Height Standard Deviation Score £ 2) and low IGF 1 (SDS 1). The demographic data obtained at the screening … visit are shown in Table 1.
Table 1. Phase 2a Demographic Data (Mean ± SD)
All 1.15 mg/kg 2.5 mg/kg 5.0 mg/kg
Patients Weekly Semi-monthly Monthly
- Prev
- 1
- Next